These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the quarterly period ended June 30, 2018
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the Transition Period from to
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
76-0346924
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
Large accelerated filer
|
|
x
|
|
Accelerated filer
|
|
¨
|
Non-accelerated filer
|
|
¨
|
|
Smaller reporting company
|
|
¨
|
|
|
|
|
Emerging growth company
|
|
¨
|
|
|
Item
|
Page
|
|
|
|
|
|
|
|
|
June 30,
2018 |
|
December 31,
2017 |
||||
|
|
|
|
|
||||
|
|
(in millions of dollars, except par values and share amounts)
|
||||||
ASSETS
|
|
|
|
|
||||
Current assets
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
482
|
|
|
$
|
1,531
|
|
Accounts receivable, net
|
|
1,261
|
|
|
1,001
|
|
||
Inventories
|
|
905
|
|
|
900
|
|
||
Prepaid expenses and other current assets
|
|
46
|
|
|
31
|
|
||
Total current assets
|
|
2,694
|
|
|
3,463
|
|
||
Property, plant and equipment, net
|
|
6,468
|
|
|
6,412
|
|
||
Goodwill
|
|
1,006
|
|
|
1,012
|
|
||
Customer relationships, net
|
|
569
|
|
|
616
|
|
||
Other intangible assets, net
|
|
149
|
|
|
161
|
|
||
Other assets, net
|
|
460
|
|
|
412
|
|
||
Total assets
|
|
$
|
11,346
|
|
|
$
|
12,076
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
||||
Current liabilities
|
|
|
|
|
||||
Accounts payable
|
|
$
|
582
|
|
|
$
|
600
|
|
Accrued liabilities
|
|
604
|
|
|
657
|
|
||
Current portion of long-term debt, net
|
|
—
|
|
|
710
|
|
||
Total current liabilities
|
|
1,186
|
|
|
1,967
|
|
||
Long-term debt, net
|
|
2,666
|
|
|
3,127
|
|
||
Deferred income taxes
|
|
1,153
|
|
|
1,111
|
|
||
Pension and other post-retirement benefits
|
|
332
|
|
|
344
|
|
||
Other liabilities
|
|
163
|
|
|
158
|
|
||
Total liabilities
|
|
5,500
|
|
|
6,707
|
|
||
Commitments and contingencies (Note 12)
|
|
|
|
|
|
|
||
Stockholders' equity
|
|
|
|
|
||||
Preferred stock, $0.01 par value, 50,000,000 shares authorized;
no shares issued and outstanding
|
|
—
|
|
|
—
|
|
||
Common stock, $0.01 par value, 300,000,000 shares authorized; 134,651,380 and
134,651,380 shares issued at June 30, 2018 and December 31, 2017, respectively
|
|
1
|
|
|
1
|
|
||
Common stock, held in treasury, at cost; 4,999,765 and 5,232,875 shares at
June 30, 2018 and December 31, 2017, respectively
|
|
(289
|
)
|
|
(302
|
)
|
||
Additional paid-in capital
|
|
558
|
|
|
555
|
|
||
Retained earnings
|
|
5,125
|
|
|
4,613
|
|
||
Accumulated other comprehensive income (loss)
|
|
(33
|
)
|
|
7
|
|
||
Total Westlake Chemical Corporation stockholders' equity
|
|
5,362
|
|
|
4,874
|
|
||
Noncontrolling interests
|
|
484
|
|
|
495
|
|
||
Total equity
|
|
5,846
|
|
|
5,369
|
|
||
Total liabilities and equity
|
|
$
|
11,346
|
|
|
$
|
12,076
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
(in millions of dollars, except per share data and share amounts)
|
||||||||||||||
Net sales
|
|
$
|
2,235
|
|
|
$
|
1,979
|
|
|
$
|
4,385
|
|
|
$
|
3,922
|
|
Cost of sales
|
|
1,683
|
|
|
1,576
|
|
|
3,291
|
|
|
3,153
|
|
||||
Gross profit
|
|
552
|
|
|
403
|
|
|
1,094
|
|
|
769
|
|
||||
Selling, general and administrative expenses
|
|
115
|
|
|
101
|
|
|
223
|
|
|
200
|
|
||||
Amortization of intangibles
|
|
25
|
|
|
30
|
|
|
51
|
|
|
55
|
|
||||
Integration-related costs
|
|
8
|
|
|
8
|
|
|
15
|
|
|
16
|
|
||||
Income from operations
|
|
404
|
|
|
264
|
|
|
805
|
|
|
498
|
|
||||
Other income (expense)
|
|
|
|
|
|
|
|
|
||||||||
Interest expense
|
|
(31
|
)
|
|
(39
|
)
|
|
(68
|
)
|
|
(79
|
)
|
||||
Other income, net
|
|
8
|
|
|
2
|
|
|
30
|
|
|
9
|
|
||||
Income before income taxes
|
|
381
|
|
|
227
|
|
|
767
|
|
|
428
|
|
||||
Provision for income taxes
|
|
93
|
|
|
68
|
|
|
182
|
|
|
124
|
|
||||
Net income
|
|
288
|
|
|
159
|
|
|
585
|
|
|
304
|
|
||||
Net income attributable to noncontrolling interests
|
|
10
|
|
|
6
|
|
|
20
|
|
|
13
|
|
||||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
278
|
|
|
$
|
153
|
|
|
$
|
565
|
|
|
$
|
291
|
|
Earnings per common share attributable to Westlake Chemical Corporation:
|
|
|
|
|
|
|
|
|
||||||||
Basic
|
|
$
|
2.13
|
|
|
$
|
1.18
|
|
|
$
|
4.34
|
|
|
$
|
2.24
|
|
Diluted
|
|
$
|
2.12
|
|
|
$
|
1.17
|
|
|
$
|
4.31
|
|
|
$
|
2.23
|
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
||||||||
Basic
|
|
129,624,291
|
|
|
129,051,227
|
|
|
129,554,528
|
|
|
129,015,507
|
|
||||
Diluted
|
|
130,306,615
|
|
|
129,786,714
|
|
|
130,249,084
|
|
|
129,739,643
|
|
||||
Dividends per common share
|
|
$
|
0.2100
|
|
|
$
|
0.1906
|
|
|
$
|
0.4200
|
|
|
$
|
0.3812
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
(in millions of dollars)
|
||||||||||||||
Net income
|
|
$
|
288
|
|
|
$
|
159
|
|
|
$
|
585
|
|
|
$
|
304
|
|
Other comprehensive income (loss), net of income taxes
|
|
|
|
|
|
|
|
|
||||||||
Pension and other post-retirement benefits liability
|
|
|
|
|
|
|
|
|
||||||||
Amortization of benefits liability
|
|
—
|
|
|
1
|
|
|
—
|
|
|
1
|
|
||||
Foreign currency translation adjustments
|
|
|
|
|
|
|
|
|
||||||||
Foreign currency translation
|
|
(37
|
)
|
|
52
|
|
|
(43
|
)
|
|
71
|
|
||||
Income tax benefit (provision) on foreign currency translation
|
|
(3
|
)
|
|
—
|
|
|
1
|
|
|
(2
|
)
|
||||
Other comprehensive income (loss), net of income taxes
|
|
(40
|
)
|
|
53
|
|
|
(42
|
)
|
|
70
|
|
||||
Comprehensive income
|
|
248
|
|
|
212
|
|
|
543
|
|
|
374
|
|
||||
Comprehensive income attributable to noncontrolling interests, net of tax of $1
for the three months ended June 30, 2018 and 2017; and net of tax of $2 for the six months
ended June 30, 2018 and 2017
|
|
6
|
|
|
7
|
|
|
18
|
|
|
15
|
|
||||
Comprehensive income attributable to Westlake Chemical Corporation
|
|
$
|
242
|
|
|
$
|
205
|
|
|
$
|
525
|
|
|
$
|
359
|
|
|
|
Common Stock
|
|
Common Stock, Held in Treasury
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
|
Number of Shares
|
|
Amount
|
|
Number of Shares
|
|
At Cost
|
|
Additional Paid-in Capital
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Income (Loss)
|
|
Noncontrolling
Interests
|
|
Total
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
|
(in millions of dollars, except share amounts)
|
||||||||||||||||||||||||||||||||
Balances at December 31, 2016
|
|
134,651,380
|
|
|
$
|
1
|
|
|
5,726,377
|
|
|
$
|
(319
|
)
|
|
$
|
551
|
|
|
$
|
3,412
|
|
|
$
|
(121
|
)
|
|
$
|
368
|
|
|
$
|
3,892
|
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
291
|
|
|
—
|
|
|
13
|
|
|
304
|
|
|||||||
Other comprehensive income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
67
|
|
|
3
|
|
|
70
|
|
|||||||
Shares issued—stock-
based compensation |
|
—
|
|
|
—
|
|
|
(127,901
|
)
|
|
3
|
|
|
(2
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|||||||
Stock-based compensation,
net of tax on stock options exercised |
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7
|
|
|||||||
Dividends declared
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(49
|
)
|
|
—
|
|
|
—
|
|
|
(49
|
)
|
|||||||
Distributions to
noncontrolling interests |
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(16
|
)
|
|
(16
|
)
|
|||||||
Balances at June 30, 2017
|
|
134,651,380
|
|
|
$
|
1
|
|
|
5,598,476
|
|
|
$
|
(316
|
)
|
|
$
|
556
|
|
|
$
|
3,654
|
|
|
$
|
(54
|
)
|
|
$
|
368
|
|
|
$
|
4,209
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Balances at December 31, 2017
|
|
134,651,380
|
|
|
$
|
1
|
|
|
5,232,875
|
|
|
$
|
(302
|
)
|
|
$
|
555
|
|
|
$
|
4,613
|
|
|
$
|
7
|
|
|
$
|
495
|
|
|
$
|
5,369
|
|
Cumulative effect of accounting change
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|||||||
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
565
|
|
|
—
|
|
|
20
|
|
|
585
|
|
|||||||
Other comprehensive loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(40
|
)
|
|
(2
|
)
|
|
(42
|
)
|
|||||||
Shares issued—stock-
based compensation
|
|
—
|
|
|
—
|
|
|
(233,110
|
)
|
|
13
|
|
|
(5
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8
|
|
|||||||
Stock-based compensation,
net of tax on stock
options exercised
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8
|
|
|||||||
Dividends declared
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(54
|
)
|
|
—
|
|
|
—
|
|
|
(54
|
)
|
|||||||
Distributions to
noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(29
|
)
|
|
(29
|
)
|
|||||||
Balances at June 30, 2018
|
|
134,651,380
|
|
|
$
|
1
|
|
|
4,999,765
|
|
|
$
|
(289
|
)
|
|
$
|
558
|
|
|
$
|
5,125
|
|
|
$
|
(33
|
)
|
|
$
|
484
|
|
|
$
|
5,846
|
|
|
|
Six Months Ended June 30,
|
||||||
|
|
2018
|
|
2017
|
||||
|
|
|
|
|
||||
|
|
(in millions of dollars)
|
||||||
Cash flows from operating activities
|
|
|
|
|
||||
Net income
|
|
$
|
585
|
|
|
$
|
304
|
|
Adjustments to reconcile net income to net cash provided by operating activities
|
|
|
|
|
||||
Depreciation and amortization
|
|
312
|
|
|
295
|
|
||
Stock-based compensation expense
|
|
11
|
|
|
11
|
|
||
Loss from disposition of property, plant and equipment
|
|
15
|
|
|
7
|
|
||
Deferred income taxes
|
|
45
|
|
|
15
|
|
||
Other gains, net
|
|
—
|
|
|
(1
|
)
|
||
Changes in operating assets and liabilities
|
|
|
|
|
||||
Accounts receivable
|
|
(272
|
)
|
|
(142
|
)
|
||
Inventories
|
|
(9
|
)
|
|
21
|
|
||
Prepaid expenses and other current assets
|
|
(13
|
)
|
|
5
|
|
||
Accounts payable
|
|
(11
|
)
|
|
82
|
|
||
Accrued liabilities
|
|
(70
|
)
|
|
(87
|
)
|
||
Other, net
|
|
(44
|
)
|
|
(30
|
)
|
||
Net cash provided by operating activities
|
|
549
|
|
|
480
|
|
||
Cash flows from investing activities
|
|
|
|
|
||||
Additions to property, plant and equipment
|
|
(312
|
)
|
|
(281
|
)
|
||
Additions to investments in unconsolidated subsidiaries
|
|
(45
|
)
|
|
(31
|
)
|
||
Other
|
|
3
|
|
|
2
|
|
||
Net cash used for investing activities
|
|
(354
|
)
|
|
(310
|
)
|
||
Cash flows from financing activities
|
|
|
|
|
||||
Dividends paid
|
|
(54
|
)
|
|
(49
|
)
|
||
Distributions to noncontrolling interests
|
|
(29
|
)
|
|
(16
|
)
|
||
Proceeds from notes payable and drawdown of revolver
|
|
6
|
|
|
178
|
|
||
Repayment of term loan
|
|
—
|
|
|
(150
|
)
|
||
Repayment of revolver
|
|
—
|
|
|
(360
|
)
|
||
Redemption and repayment of notes payable
|
|
(1,173
|
)
|
|
(5
|
)
|
||
Other
|
|
8
|
|
|
1
|
|
||
Net cash used for financing activities
|
|
(1,242
|
)
|
|
(401
|
)
|
||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
|
(2
|
)
|
|
13
|
|
||
Net decrease in cash, cash equivalents and restricted cash
|
|
(1,049
|
)
|
|
(218
|
)
|
||
Cash, cash equivalents and restricted cash at beginning of period
|
|
1,554
|
|
|
646
|
|
||
Cash, cash equivalents and restricted cash at end of period
|
|
$
|
505
|
|
|
$
|
428
|
|
|
|
June 30,
2018 |
|
December 31,
2017 |
||||
Trade customers
|
|
$
|
1,198
|
|
|
$
|
974
|
|
Affiliates
|
|
12
|
|
|
9
|
|
||
Allowance for doubtful accounts
|
|
(24
|
)
|
|
(22
|
)
|
||
|
|
1,186
|
|
|
961
|
|
||
Federal and state taxes
|
|
48
|
|
|
7
|
|
||
Other
|
|
27
|
|
|
33
|
|
||
Accounts receivable, net
|
|
$
|
1,261
|
|
|
$
|
1,001
|
|
|
|
June 30,
2018 |
|
December 31,
2017 |
||||
Finished products
|
|
$
|
552
|
|
|
$
|
549
|
|
Feedstock, additives and chemicals
|
|
209
|
|
|
221
|
|
||
Materials and supplies
|
|
144
|
|
|
130
|
|
||
Inventories
|
|
$
|
905
|
|
|
$
|
900
|
|
|
|
Olefins Segment
|
|
Vinyls Segment
|
|
Total
|
||||||
Balances at December 31, 2017
|
|
$
|
30
|
|
|
$
|
982
|
|
|
$
|
1,012
|
|
Effects of changes in foreign exchange rates
|
|
—
|
|
|
(6
|
)
|
|
(6
|
)
|
|||
Balances at June 30, 2018
|
|
$
|
30
|
|
|
$
|
976
|
|
|
$
|
1,006
|
|
|
|
June 30, 2018
|
|
December 31, 2017
|
||||||||||||||||||||
|
|
Principal
Amount |
|
Unamortized
Discount
and Debt Issuance Costs |
|
Net
Long-term Debt |
|
Principal
Amount |
|
Unamortized
Premium, Discount and Debt Issuance Costs |
|
Net
Long-term Debt |
||||||||||||
3.60% senior notes due 2022 (the "3.60% 2022 Senior Notes")
|
|
$
|
250
|
|
|
$
|
(1
|
)
|
|
$
|
249
|
|
|
$
|
250
|
|
|
$
|
(1
|
)
|
|
$
|
249
|
|
3.60% senior notes due 2026 (the "3.60% 2026 Senior Notes")
|
|
750
|
|
|
(9
|
)
|
|
741
|
|
|
750
|
|
|
(10
|
)
|
|
740
|
|
||||||
Loan related to tax-exempt waste disposal revenue bonds due 2027
|
|
11
|
|
|
—
|
|
|
11
|
|
|
11
|
|
|
—
|
|
|
11
|
|
||||||
6 ½% senior notes due 2029 (the "6 ½% 2029 GO Zone Senior Notes")
|
|
100
|
|
|
(1
|
)
|
|
99
|
|
|
100
|
|
|
(1
|
)
|
|
99
|
|
||||||
6 ½% senior notes due 2035 (the "6 ½% 2035 GO Zone Senior Notes")
|
|
89
|
|
|
(1
|
)
|
|
88
|
|
|
89
|
|
|
(1
|
)
|
|
88
|
|
||||||
6 ½% senior notes due 2035 (the "6 ½% 2035 IKE Zone Senior Notes")
|
|
65
|
|
|
(1
|
)
|
|
64
|
|
|
65
|
|
|
—
|
|
|
65
|
|
||||||
5.0% senior notes due 2046 (the "5.0% 2046 Senior Notes")
|
|
700
|
|
|
(25
|
)
|
|
675
|
|
|
700
|
|
|
(25
|
)
|
|
675
|
|
||||||
4.375% senior notes due 2047 (the "4.375% 2047 Senior Notes")
|
|
500
|
|
|
(9
|
)
|
|
491
|
|
|
500
|
|
|
(9
|
)
|
|
491
|
|
||||||
3.50% senior notes due 2032 (the "3.50% 2032 GO Zone Refunding Senior Notes")
|
|
250
|
|
|
(2
|
)
|
|
248
|
|
|
250
|
|
|
(2
|
)
|
|
248
|
|
||||||
4.625% senior notes due 2021 (the "4.625% Westlake 2021 Senior Notes")
|
|
—
|
|
|
—
|
|
|
—
|
|
|
625
|
|
|
20
|
|
|
645
|
|
||||||
4.625% senior notes due 2021 (the "4.625% Subsidiary 2021 Senior Notes")
|
|
—
|
|
|
—
|
|
|
—
|
|
|
63
|
|
|
2
|
|
|
65
|
|
||||||
4.875% senior notes due 2023 (the "4.875% Westlake 2023 Senior Notes")
|
|
—
|
|
|
—
|
|
|
—
|
|
|
434
|
|
|
11
|
|
|
445
|
|
||||||
4.875% senior notes due 2023 (the "4.875% Subsidiary 2023 Senior Notes")
|
|
—
|
|
|
—
|
|
|
—
|
|
|
16
|
|
|
—
|
|
|
16
|
|
||||||
Total Long-term debt
|
|
2,715
|
|
|
(49
|
)
|
|
2,666
|
|
|
3,853
|
|
|
(16
|
)
|
|
3,837
|
|
||||||
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Current portion - 4.625% Westlake 2021 Senior Notes and 4.625% Subsidiary 2021 Senior Notes
|
|
—
|
|
|
—
|
|
|
—
|
|
|
688
|
|
|
22
|
|
|
710
|
|
||||||
Long-term debt, net of current portion
|
|
$
|
2,715
|
|
|
$
|
(49
|
)
|
|
$
|
2,666
|
|
|
$
|
3,165
|
|
|
$
|
(38
|
)
|
|
$
|
3,127
|
|
|
|
Benefits
Liability,
Net of Tax
|
|
Cumulative
Foreign
Currency
Exchange,
Net of Tax
|
|
Total
|
||||||
Balances at December 31, 2016
|
|
$
|
29
|
|
|
$
|
(150
|
)
|
|
$
|
(121
|
)
|
Other comprehensive income before reclassifications
|
|
—
|
|
|
66
|
|
|
66
|
|
|||
Amounts reclassified from accumulated other
comprehensive income |
|
1
|
|
|
—
|
|
|
1
|
|
|||
Net other comprehensive income attributable
to Westlake Chemical Corporation |
|
1
|
|
|
66
|
|
|
67
|
|
|||
Balances at June 30, 2017
|
|
$
|
30
|
|
|
$
|
(84
|
)
|
|
$
|
(54
|
)
|
|
|
|
|
|
|
|
||||||
Balances at December 31, 2017
|
|
$
|
43
|
|
|
$
|
(36
|
)
|
|
$
|
7
|
|
Other comprehensive loss before reclassifications
|
|
—
|
|
|
(40
|
)
|
|
(40
|
)
|
|||
Net other comprehensive loss attributable
to Westlake Chemical Corporation
|
|
—
|
|
|
(40
|
)
|
|
(40
|
)
|
|||
Balances at June 30, 2018
|
|
$
|
43
|
|
|
$
|
(76
|
)
|
|
$
|
(33
|
)
|
|
|
June 30, 2018
|
|
December 31, 2017
|
||||||||||||
|
|
Carrying
Value
|
|
Fair
Value
|
|
Carrying
Value
|
|
Fair
Value
|
||||||||
3.60% 2022 Senior Notes
|
|
$
|
249
|
|
|
$
|
247
|
|
|
$
|
249
|
|
|
$
|
255
|
|
3.60% 2026 Senior Notes
|
|
741
|
|
|
711
|
|
|
740
|
|
|
757
|
|
||||
Loan related to tax-exempt waste disposal revenue bonds
due 2027
|
|
11
|
|
|
11
|
|
|
11
|
|
|
11
|
|
||||
6 ½% 2029 GO Zone Senior Notes
|
|
99
|
|
|
109
|
|
|
99
|
|
|
111
|
|
||||
6 ½% 2035 GO Zone Senior Notes
|
|
88
|
|
|
98
|
|
|
88
|
|
|
99
|
|
||||
6 ½% 2035 IKE Zone Senior Notes
|
|
64
|
|
|
71
|
|
|
65
|
|
|
74
|
|
||||
5.0% 2046 Senior Notes
|
|
675
|
|
|
708
|
|
|
675
|
|
|
787
|
|
||||
4.375% 2047 Senior Notes
|
|
491
|
|
|
462
|
|
|
491
|
|
|
518
|
|
||||
3.50% 2032 GO Zone Refunding Senior Notes
|
|
248
|
|
|
247
|
|
|
248
|
|
|
256
|
|
||||
4.625% Westlake 2021 Senior Notes
|
|
—
|
|
|
—
|
|
|
645
|
|
|
639
|
|
||||
4.625% Subsidiary 2021 Senior Notes
|
|
—
|
|
|
—
|
|
|
65
|
|
|
65
|
|
||||
4.875% Westlake 2023 Senior Notes
|
|
—
|
|
|
—
|
|
|
445
|
|
|
449
|
|
||||
4.875% Subsidiary 2023 Senior Notes
|
|
—
|
|
|
—
|
|
|
16
|
|
|
16
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
278
|
|
|
$
|
153
|
|
|
$
|
565
|
|
|
$
|
291
|
|
Less:
|
|
|
|
|
|
|
|
|
||||||||
Net income attributable to participating securities
|
|
(2
|
)
|
|
(1
|
)
|
|
(3
|
)
|
|
(2
|
)
|
||||
Net income attributable to common shareholders
|
|
$
|
276
|
|
|
$
|
152
|
|
|
$
|
562
|
|
|
$
|
289
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Weighted average common shares—basic
|
|
129,624,291
|
|
|
129,051,227
|
|
|
129,554,528
|
|
|
129,015,507
|
|
||||
Plus incremental shares from:
|
|
|
|
|
|
|
|
|
||||||||
Assumed exercise of options
|
|
682,324
|
|
|
735,487
|
|
|
694,556
|
|
|
724,136
|
|
||||
Weighted average common shares—diluted
|
|
130,306,615
|
|
|
129,786,714
|
|
|
130,249,084
|
|
|
129,739,643
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Earnings per common share attributable to Westlake Chemical Corporation:
|
|
|
|
|
|
|
|
|
||||||||
Basic
|
|
$
|
2.13
|
|
|
$
|
1.18
|
|
|
$
|
4.34
|
|
|
$
|
2.24
|
|
Diluted
|
|
$
|
2.12
|
|
|
$
|
1.17
|
|
|
$
|
4.31
|
|
|
$
|
2.23
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Net external sales
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
|
|
|
|
|
|
|
||||||||
Polyethylene
|
|
$
|
387
|
|
|
$
|
358
|
|
|
$
|
756
|
|
|
$
|
744
|
|
Styrene, feedstock and other
|
|
95
|
|
|
131
|
|
|
229
|
|
|
288
|
|
||||
Total Olefins
|
|
482
|
|
|
489
|
|
|
985
|
|
|
1,032
|
|
||||
Vinyls
|
|
|
|
|
|
|
|
|
||||||||
PVC, caustic soda and other
|
|
1,396
|
|
|
1,157
|
|
|
2,754
|
|
|
2,288
|
|
||||
Building products
|
|
357
|
|
|
333
|
|
|
646
|
|
|
602
|
|
||||
Total Vinyls
|
|
1,753
|
|
|
1,490
|
|
|
3,400
|
|
|
2,890
|
|
||||
|
|
$
|
2,235
|
|
|
$
|
1,979
|
|
|
$
|
4,385
|
|
|
$
|
3,922
|
|
|
|
|
|
|
|
|
|
|
||||||||
Intersegment sales
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
$
|
112
|
|
|
$
|
98
|
|
|
$
|
232
|
|
|
$
|
184
|
|
Vinyls
|
|
1
|
|
|
—
|
|
|
1
|
|
|
—
|
|
||||
|
|
$
|
113
|
|
|
$
|
98
|
|
|
$
|
233
|
|
|
$
|
184
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Income (loss) from operations
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
$
|
158
|
|
|
$
|
143
|
|
|
$
|
321
|
|
|
$
|
323
|
|
Vinyls
|
|
271
|
|
|
141
|
|
|
537
|
|
|
211
|
|
||||
Corporate and other
|
|
(25
|
)
|
|
(20
|
)
|
|
(53
|
)
|
|
(36
|
)
|
||||
|
|
$
|
404
|
|
|
$
|
264
|
|
|
$
|
805
|
|
|
$
|
498
|
|
|
|
|
|
|
|
|
|
|
||||||||
Depreciation and amortization
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
$
|
33
|
|
|
$
|
35
|
|
|
$
|
67
|
|
|
$
|
76
|
|
Vinyls
|
|
120
|
|
|
107
|
|
|
238
|
|
|
214
|
|
||||
Corporate and other
|
|
3
|
|
|
3
|
|
|
7
|
|
|
5
|
|
||||
|
|
$
|
156
|
|
|
$
|
145
|
|
|
$
|
312
|
|
|
$
|
295
|
|
|
|
|
|
|
|
|
|
|
||||||||
Other income, net
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
$
|
1
|
|
|
$
|
1
|
|
|
$
|
3
|
|
|
$
|
2
|
|
Vinyls
|
|
4
|
|
|
—
|
|
|
16
|
|
|
6
|
|
||||
Corporate and other
|
|
3
|
|
|
1
|
|
|
11
|
|
|
1
|
|
||||
|
|
$
|
8
|
|
|
$
|
2
|
|
|
$
|
30
|
|
|
$
|
9
|
|
|
|
|
|
|
|
|
|
|
||||||||
Provision for (benefit from) income taxes
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
$
|
36
|
|
|
$
|
36
|
|
|
$
|
73
|
|
|
$
|
94
|
|
Vinyls
|
|
69
|
|
|
39
|
|
|
130
|
|
|
54
|
|
||||
Corporate and other
|
|
(12
|
)
|
|
(7
|
)
|
|
(21
|
)
|
|
(24
|
)
|
||||
|
|
$
|
93
|
|
|
$
|
68
|
|
|
$
|
182
|
|
|
$
|
124
|
|
|
|
|
|
|
|
|
|
|
||||||||
Capital expenditures
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
$
|
26
|
|
|
$
|
24
|
|
|
$
|
48
|
|
|
$
|
49
|
|
Vinyls
|
|
128
|
|
|
114
|
|
|
258
|
|
|
222
|
|
||||
Corporate and other
|
|
4
|
|
|
9
|
|
|
6
|
|
|
10
|
|
||||
|
|
$
|
158
|
|
|
$
|
147
|
|
|
$
|
312
|
|
|
$
|
281
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Income from operations
|
|
$
|
404
|
|
|
$
|
264
|
|
|
$
|
805
|
|
|
$
|
498
|
|
Interest expense
|
|
(31
|
)
|
|
(39
|
)
|
|
(68
|
)
|
|
(79
|
)
|
||||
Other income, net
|
|
8
|
|
|
2
|
|
|
30
|
|
|
9
|
|
||||
Income before income taxes
|
|
$
|
381
|
|
|
$
|
227
|
|
|
$
|
767
|
|
|
$
|
428
|
|
|
|
June 30,
2018 |
|
December 31,
2017 |
||||
Total assets
|
|
|
|
|
||||
Olefins
|
|
$
|
2,044
|
|
|
$
|
2,006
|
|
Vinyls
|
|
8,863
|
|
|
8,853
|
|
||
Corporate and other
|
|
439
|
|
|
1,217
|
|
||
|
|
$
|
11,346
|
|
|
$
|
12,076
|
|
|
|
Marginal Percentage Interest in Distributions
|
||||
Total Quarterly Distribution Per Unit
|
|
Unitholders
|
|
IDR Holders
|
||
Above $1.2938 up to $1.4063
|
|
85.0
|
%
|
|
15.0
|
%
|
Above $1.4063 up to $1.6875
|
|
75.0
|
%
|
|
25.0
|
%
|
Above $1.6875
|
|
50.0
|
%
|
|
50.0
|
%
|
|
|
Marginal Percentage Interest in Distributions
|
||||
Total Quarterly Distribution Per Unit
|
|
Unitholders
|
|
IDR Holders
|
||
Above $0.3163 up to $0.3438
|
|
85.0
|
%
|
|
15.0
|
%
|
Above $0.3438 up to $0.4125
|
|
75.0
|
%
|
|
25.0
|
%
|
Above $0.4125
|
|
50.0
|
%
|
|
50.0
|
%
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Balance Sheet
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Current assets
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
|
$
|
258
|
|
|
$
|
40
|
|
|
$
|
184
|
|
|
$
|
—
|
|
|
$
|
482
|
|
Accounts receivable, net
|
|
4,963
|
|
|
5,488
|
|
|
666
|
|
|
(9,856
|
)
|
|
1,261
|
|
|||||
Inventories
|
|
—
|
|
|
651
|
|
|
254
|
|
|
—
|
|
|
905
|
|
|||||
Prepaid expenses and other current assets
|
|
158
|
|
|
39
|
|
|
23
|
|
|
(174
|
)
|
|
46
|
|
|||||
Total current assets
|
|
5,379
|
|
|
6,218
|
|
|
1,127
|
|
|
(10,030
|
)
|
|
2,694
|
|
|||||
Property, plant and equipment, net
|
|
—
|
|
|
4,466
|
|
|
2,002
|
|
|
—
|
|
|
6,468
|
|
|||||
Goodwill
|
|
—
|
|
|
855
|
|
|
151
|
|
|
—
|
|
|
1,006
|
|
|||||
Customer relationships, net
|
|
—
|
|
|
447
|
|
|
122
|
|
|
—
|
|
|
569
|
|
|||||
Other intangible assets, net
|
|
—
|
|
|
81
|
|
|
68
|
|
|
—
|
|
|
149
|
|
|||||
Other assets, net
|
|
11,188
|
|
|
800
|
|
|
1,312
|
|
|
(12,840
|
)
|
|
460
|
|
|||||
Total assets
|
|
$
|
16,567
|
|
|
$
|
12,867
|
|
|
$
|
4,782
|
|
|
$
|
(22,870
|
)
|
|
$
|
11,346
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Accounts payable
|
|
$
|
8,356
|
|
|
$
|
1,675
|
|
|
$
|
231
|
|
|
$
|
(9,680
|
)
|
|
$
|
582
|
|
Accrued liabilities
|
|
183
|
|
|
514
|
|
|
255
|
|
|
(348
|
)
|
|
604
|
|
|||||
Total current liabilities
|
|
8,539
|
|
|
2,189
|
|
|
486
|
|
|
(10,028
|
)
|
|
1,186
|
|
|||||
Long-term debt, net
|
|
2,656
|
|
|
4,161
|
|
|
224
|
|
|
(4,375
|
)
|
|
2,666
|
|
|||||
Deferred income taxes
|
|
—
|
|
|
1,072
|
|
|
94
|
|
|
(13
|
)
|
|
1,153
|
|
|||||
Pension and other liabilities
|
|
10
|
|
|
336
|
|
|
149
|
|
|
—
|
|
|
495
|
|
|||||
Total liabilities
|
|
11,205
|
|
|
7,758
|
|
|
953
|
|
|
(14,416
|
)
|
|
5,500
|
|
|||||
Total Westlake Chemical Corporation stockholders' equity
|
|
5,362
|
|
|
5,109
|
|
|
3,345
|
|
|
(8,454
|
)
|
|
5,362
|
|
|||||
Noncontrolling interests
|
|
—
|
|
|
—
|
|
|
484
|
|
|
—
|
|
|
484
|
|
|||||
Total equity
|
|
5,362
|
|
|
5,109
|
|
|
3,829
|
|
|
(8,454
|
)
|
|
5,846
|
|
|||||
Total liabilities and equity
|
|
$
|
16,567
|
|
|
$
|
12,867
|
|
|
$
|
4,782
|
|
|
$
|
(22,870
|
)
|
|
$
|
11,346
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Balance Sheet
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Current assets
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
|
$
|
1,089
|
|
|
$
|
57
|
|
|
$
|
385
|
|
|
$
|
—
|
|
|
$
|
1,531
|
|
Accounts receivable, net
|
|
3,331
|
|
|
4,128
|
|
|
580
|
|
|
(7,038
|
)
|
|
1,001
|
|
|||||
Inventories
|
|
—
|
|
|
654
|
|
|
246
|
|
|
—
|
|
|
900
|
|
|||||
Prepaid expenses and other current assets
|
|
52
|
|
|
27
|
|
|
31
|
|
|
(79
|
)
|
|
31
|
|
|||||
Total current assets
|
|
4,472
|
|
|
4,866
|
|
|
1,242
|
|
|
(7,117
|
)
|
|
3,463
|
|
|||||
Property, plant and equipment, net
|
|
—
|
|
|
4,374
|
|
|
2,038
|
|
|
—
|
|
|
6,412
|
|
|||||
Goodwill
|
|
—
|
|
|
855
|
|
|
157
|
|
|
—
|
|
|
1,012
|
|
|||||
Customer relationships, net
|
|
—
|
|
|
479
|
|
|
137
|
|
|
—
|
|
|
616
|
|
|||||
Other intangible assets, net
|
|
—
|
|
|
88
|
|
|
73
|
|
|
—
|
|
|
161
|
|
|||||
Other assets, net
|
|
10,706
|
|
|
798
|
|
|
1,271
|
|
|
(12,363
|
)
|
|
412
|
|
|||||
Total assets
|
|
$
|
15,178
|
|
|
$
|
11,460
|
|
|
$
|
4,918
|
|
|
$
|
(19,480
|
)
|
|
$
|
12,076
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Accounts payable
|
|
$
|
6,367
|
|
|
$
|
864
|
|
|
$
|
224
|
|
|
$
|
(6,855
|
)
|
|
$
|
600
|
|
Accrued liabilities
|
|
189
|
|
|
484
|
|
|
246
|
|
|
(262
|
)
|
|
657
|
|
|||||
Current portion of long-term debt, net
|
|
710
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
710
|
|
|||||
Total current liabilities
|
|
7,266
|
|
|
1,348
|
|
|
470
|
|
|
(7,117
|
)
|
|
1,967
|
|
|||||
Long-term debt, net
|
|
3,034
|
|
|
4,242
|
|
|
220
|
|
|
(4,369
|
)
|
|
3,127
|
|
|||||
Deferred income taxes
|
|
—
|
|
|
1,026
|
|
|
92
|
|
|
(7
|
)
|
|
1,111
|
|
|||||
Pension and other liabilities
|
|
4
|
|
|
347
|
|
|
151
|
|
|
—
|
|
|
502
|
|
|||||
Total liabilities
|
|
10,304
|
|
|
6,963
|
|
|
933
|
|
|
(11,493
|
)
|
|
6,707
|
|
|||||
Total Westlake Chemical Corporation stockholders' equity
|
|
4,874
|
|
|
4,497
|
|
|
3,490
|
|
|
(7,987
|
)
|
|
4,874
|
|
|||||
Noncontrolling interests
|
|
—
|
|
|
—
|
|
|
495
|
|
|
—
|
|
|
495
|
|
|||||
Total equity
|
|
4,874
|
|
|
4,497
|
|
|
3,985
|
|
|
(7,987
|
)
|
|
5,369
|
|
|||||
Total liabilities and equity
|
|
$
|
15,178
|
|
|
$
|
11,460
|
|
|
$
|
4,918
|
|
|
$
|
(19,480
|
)
|
|
$
|
12,076
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales
|
|
$
|
—
|
|
|
$
|
1,826
|
|
|
$
|
878
|
|
|
$
|
(469
|
)
|
|
$
|
2,235
|
|
Cost of sales
|
|
—
|
|
|
1,465
|
|
|
680
|
|
|
(462
|
)
|
|
1,683
|
|
|||||
Gross profit
|
|
—
|
|
|
361
|
|
|
198
|
|
|
(7
|
)
|
|
552
|
|
|||||
Selling, general and administrative expenses
|
|
—
|
|
|
86
|
|
|
36
|
|
|
(7
|
)
|
|
115
|
|
|||||
Amortization of intangibles
|
|
—
|
|
|
19
|
|
|
6
|
|
|
—
|
|
|
25
|
|
|||||
Integration-related costs
|
|
—
|
|
|
8
|
|
|
—
|
|
|
—
|
|
|
8
|
|
|||||
Income from operations
|
|
—
|
|
|
248
|
|
|
156
|
|
|
—
|
|
|
404
|
|
|||||
Other income (expense)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest expense
|
|
(31
|
)
|
|
(52
|
)
|
|
(3
|
)
|
|
55
|
|
|
(31
|
)
|
|||||
Other income (expense), net
|
|
41
|
|
|
8
|
|
|
14
|
|
|
(55
|
)
|
|
8
|
|
|||||
Income (loss) before income taxes
|
|
10
|
|
|
204
|
|
|
167
|
|
|
—
|
|
|
381
|
|
|||||
Provision (benefit) for income taxes
|
|
2
|
|
|
71
|
|
|
20
|
|
|
—
|
|
|
93
|
|
|||||
Equity in net income of subsidiaries
|
|
270
|
|
|
—
|
|
|
—
|
|
|
(270
|
)
|
|
—
|
|
|||||
Net income
|
|
278
|
|
|
133
|
|
|
147
|
|
|
(270
|
)
|
|
288
|
|
|||||
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
10
|
|
|
—
|
|
|
10
|
|
|||||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
278
|
|
|
$
|
133
|
|
|
$
|
137
|
|
|
$
|
(270
|
)
|
|
$
|
278
|
|
Comprehensive income attributable to Westlake Chemical Corporation
|
|
$
|
242
|
|
|
$
|
133
|
|
|
$
|
99
|
|
|
$
|
(232
|
)
|
|
$
|
242
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales
|
|
$
|
—
|
|
|
$
|
1,597
|
|
|
$
|
804
|
|
|
$
|
(422
|
)
|
|
$
|
1,979
|
|
Cost of sales
|
|
—
|
|
|
1,350
|
|
|
640
|
|
|
(414
|
)
|
|
1,576
|
|
|||||
Gross profit
|
|
—
|
|
|
247
|
|
|
164
|
|
|
(8
|
)
|
|
403
|
|
|||||
Selling, general and administrative expenses
|
|
—
|
|
|
73
|
|
|
36
|
|
|
(8
|
)
|
|
101
|
|
|||||
Amortization of intangibles
|
|
—
|
|
|
23
|
|
|
7
|
|
|
—
|
|
|
30
|
|
|||||
Integration-related costs
|
|
—
|
|
|
8
|
|
|
—
|
|
|
—
|
|
|
8
|
|
|||||
Income from operations
|
|
—
|
|
|
143
|
|
|
121
|
|
|
—
|
|
|
264
|
|
|||||
Other income (expense)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest expense
|
|
(38
|
)
|
|
(46
|
)
|
|
—
|
|
|
45
|
|
|
(39
|
)
|
|||||
Other income (expense), net
|
|
37
|
|
|
6
|
|
|
4
|
|
|
(45
|
)
|
|
2
|
|
|||||
Income (loss) before income taxes
|
|
(1
|
)
|
|
103
|
|
|
125
|
|
|
—
|
|
|
227
|
|
|||||
Provision (benefit) for income taxes
|
|
4
|
|
|
52
|
|
|
12
|
|
|
—
|
|
|
68
|
|
|||||
Equity in net income of subsidiaries
|
|
158
|
|
|
—
|
|
|
—
|
|
|
(158
|
)
|
|
—
|
|
|||||
Net income
|
|
153
|
|
|
51
|
|
|
113
|
|
|
(158
|
)
|
|
159
|
|
|||||
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
6
|
|
|
—
|
|
|
6
|
|
|||||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
153
|
|
|
$
|
51
|
|
|
$
|
107
|
|
|
$
|
(158
|
)
|
|
$
|
153
|
|
Comprehensive income attributable to Westlake Chemical Corporation
|
|
$
|
205
|
|
|
$
|
52
|
|
|
$
|
148
|
|
|
$
|
(200
|
)
|
|
$
|
205
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales
|
|
$
|
—
|
|
|
$
|
3,572
|
|
|
$
|
1,717
|
|
|
$
|
(904
|
)
|
|
$
|
4,385
|
|
Cost of sales
|
|
—
|
|
|
2,870
|
|
|
1,312
|
|
|
(891
|
)
|
|
3,291
|
|
|||||
Gross profit
|
|
—
|
|
|
702
|
|
|
405
|
|
|
(13
|
)
|
|
1,094
|
|
|||||
Selling, general and administrative expenses
|
|
—
|
|
|
163
|
|
|
73
|
|
|
(13
|
)
|
|
223
|
|
|||||
Amortization of intangibles
|
|
—
|
|
|
38
|
|
|
13
|
|
|
—
|
|
|
51
|
|
|||||
Integration-related costs
|
|
—
|
|
|
15
|
|
|
—
|
|
|
—
|
|
|
15
|
|
|||||
Income from operations
|
|
—
|
|
|
486
|
|
|
319
|
|
|
—
|
|
|
805
|
|
|||||
Other income (expense)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest expense
|
|
(69
|
)
|
|
(100
|
)
|
|
(5
|
)
|
|
106
|
|
|
(68
|
)
|
|||||
Other income (expense), net
|
|
86
|
|
|
16
|
|
|
34
|
|
|
(106
|
)
|
|
30
|
|
|||||
Income (loss) before income taxes
|
|
17
|
|
|
402
|
|
|
348
|
|
|
—
|
|
|
767
|
|
|||||
Provision (benefit) for income taxes
|
|
4
|
|
|
134
|
|
|
44
|
|
|
—
|
|
|
182
|
|
|||||
Equity in net income of subsidiaries
|
|
552
|
|
|
—
|
|
|
—
|
|
|
(552
|
)
|
|
—
|
|
|||||
Net income
|
|
565
|
|
|
268
|
|
|
304
|
|
|
(552
|
)
|
|
585
|
|
|||||
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
20
|
|
|
—
|
|
|
20
|
|
|||||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
565
|
|
|
$
|
268
|
|
|
$
|
284
|
|
|
$
|
(552
|
)
|
|
$
|
565
|
|
Comprehensive income attributable to Westlake Chemical Corporation
|
|
$
|
525
|
|
|
$
|
268
|
|
|
$
|
244
|
|
|
$
|
(512
|
)
|
|
$
|
525
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales
|
|
$
|
—
|
|
|
$
|
3,177
|
|
|
$
|
1,540
|
|
|
$
|
(795
|
)
|
|
$
|
3,922
|
|
Cost of sales
|
|
—
|
|
|
2,712
|
|
|
1,222
|
|
|
(781
|
)
|
|
3,153
|
|
|||||
Gross profit
|
|
—
|
|
|
465
|
|
|
318
|
|
|
(14
|
)
|
|
769
|
|
|||||
Selling, general and administrative expenses
|
|
1
|
|
|
146
|
|
|
67
|
|
|
(14
|
)
|
|
200
|
|
|||||
Amortization of intangibles
|
|
—
|
|
|
42
|
|
|
13
|
|
|
—
|
|
|
55
|
|
|||||
Integration-related costs
|
|
—
|
|
|
16
|
|
|
—
|
|
|
—
|
|
|
16
|
|
|||||
Income from operations
|
|
(1
|
)
|
|
261
|
|
|
238
|
|
|
—
|
|
|
498
|
|
|||||
Other income (expense)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest expense
|
|
(76
|
)
|
|
(92
|
)
|
|
(1
|
)
|
|
90
|
|
|
(79
|
)
|
|||||
Other income (expense), net
|
|
74
|
|
|
9
|
|
|
16
|
|
|
(90
|
)
|
|
9
|
|
|||||
Income (loss) before income taxes
|
|
(3
|
)
|
|
178
|
|
|
253
|
|
|
—
|
|
|
428
|
|
|||||
Provision (benefit) for income taxes
|
|
(1
|
)
|
|
105
|
|
|
20
|
|
|
—
|
|
|
124
|
|
|||||
Equity in net income of subsidiaries
|
|
293
|
|
|
—
|
|
|
—
|
|
|
(293
|
)
|
|
—
|
|
|||||
Net income
|
|
291
|
|
|
73
|
|
|
233
|
|
|
(293
|
)
|
|
304
|
|
|||||
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
13
|
|
|
—
|
|
|
13
|
|
|||||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
291
|
|
|
$
|
73
|
|
|
$
|
220
|
|
|
$
|
(293
|
)
|
|
$
|
291
|
|
Comprehensive income attributable to Westlake Chemical Corporation
|
|
$
|
359
|
|
|
$
|
73
|
|
|
$
|
259
|
|
|
$
|
(332
|
)
|
|
$
|
359
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net income
|
|
$
|
565
|
|
|
$
|
268
|
|
|
$
|
304
|
|
|
$
|
(552
|
)
|
|
$
|
585
|
|
Adjustments to reconcile net income to net cash provided by operating activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation and amortization
|
|
—
|
|
|
208
|
|
|
104
|
|
|
—
|
|
|
312
|
|
|||||
Deferred income taxes
|
|
1
|
|
|
40
|
|
|
4
|
|
|
—
|
|
|
45
|
|
|||||
Net changes in working capital and other
|
|
(533
|
)
|
|
(459
|
)
|
|
47
|
|
|
552
|
|
|
(393
|
)
|
|||||
Net cash provided by operating activities
|
|
33
|
|
|
57
|
|
|
459
|
|
|
—
|
|
|
549
|
|
|||||
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Additions to property, plant and equipment
|
|
—
|
|
|
(248
|
)
|
|
(64
|
)
|
|
—
|
|
|
(312
|
)
|
|||||
Additions to investments in unconsolidated subsidiaries
|
|
—
|
|
|
(35
|
)
|
|
(10
|
)
|
|
—
|
|
|
(45
|
)
|
|||||
Other
|
|
—
|
|
|
3
|
|
|
—
|
|
|
—
|
|
|
3
|
|
|||||
Net cash used for investing activities
|
|
—
|
|
|
(280
|
)
|
|
(74
|
)
|
|
—
|
|
|
(354
|
)
|
|||||
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Intercompany financing
|
|
347
|
|
|
(1
|
)
|
|
(346
|
)
|
|
—
|
|
|
—
|
|
|||||
Dividends paid
|
|
(54
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(54
|
)
|
|||||
Distributions to noncontrolling interests
|
|
—
|
|
|
207
|
|
|
(236
|
)
|
|
—
|
|
|
(29
|
)
|
|||||
Proceeds from notes payable and drawdown of revolver
|
|
—
|
|
|
—
|
|
|
6
|
|
|
—
|
|
|
6
|
|
|||||
Redemption and repayment of notes payable
|
|
(1,165
|
)
|
|
—
|
|
|
(8
|
)
|
|
—
|
|
|
(1,173
|
)
|
|||||
Other
|
|
8
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8
|
|
|||||
Net cash used for financing activities
|
|
(864
|
)
|
|
206
|
|
|
(584
|
)
|
|
—
|
|
|
(1,242
|
)
|
|||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
—
|
|
|
(2
|
)
|
|||||
Net decrease in cash, cash equivalents and restricted cash
|
|
(831
|
)
|
|
(17
|
)
|
|
(201
|
)
|
|
—
|
|
|
(1,049
|
)
|
|||||
Cash, cash equivalents and restricted cash at beginning of period
|
|
1,089
|
|
|
79
|
|
|
386
|
|
|
—
|
|
|
1,554
|
|
|||||
Cash, cash equivalents and restricted cash at end of period
|
|
$
|
258
|
|
|
$
|
62
|
|
|
$
|
185
|
|
|
$
|
—
|
|
|
$
|
505
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net income
|
|
$
|
291
|
|
|
$
|
73
|
|
|
$
|
233
|
|
|
$
|
(293
|
)
|
|
$
|
304
|
|
Adjustments to reconcile net income to net cash provided by operating activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation and amortization
|
|
—
|
|
|
194
|
|
|
101
|
|
|
—
|
|
|
295
|
|
|||||
Deferred income taxes
|
|
—
|
|
|
15
|
|
|
—
|
|
|
—
|
|
|
15
|
|
|||||
Net changes in working capital and other
|
|
(400
|
)
|
|
(26
|
)
|
|
(1
|
)
|
|
293
|
|
|
(134
|
)
|
|||||
Net cash provided by (used for) operating activities
|
|
(109
|
)
|
|
256
|
|
|
333
|
|
|
—
|
|
|
480
|
|
|||||
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Additions to property, plant and equipment
|
|
—
|
|
|
(199
|
)
|
|
(82
|
)
|
|
—
|
|
|
(281
|
)
|
|||||
Additions to investments in unconsolidated subsidiaries
|
|
—
|
|
|
(31
|
)
|
|
—
|
|
|
—
|
|
|
(31
|
)
|
|||||
Other
|
|
—
|
|
|
2
|
|
|
—
|
|
|
—
|
|
|
2
|
|
|||||
Net cash used for investing activities
|
|
—
|
|
|
(228
|
)
|
|
(82
|
)
|
|
—
|
|
|
(310
|
)
|
|||||
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Intercompany financing
|
|
242
|
|
|
(254
|
)
|
|
12
|
|
|
—
|
|
|
—
|
|
|||||
Dividends paid
|
|
(49
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(49
|
)
|
|||||
Distributions to noncontrolling interests
|
|
—
|
|
|
189
|
|
|
(205
|
)
|
|
—
|
|
|
(16
|
)
|
|||||
Proceeds from notes payable and drawdown of revolver
|
|
175
|
|
|
—
|
|
|
3
|
|
|
—
|
|
|
178
|
|
|||||
Repayment of term loan
|
|
—
|
|
|
—
|
|
|
(150
|
)
|
|
—
|
|
|
(150
|
)
|
|||||
Repayment of revolver
|
|
(360
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(360
|
)
|
|||||
Redemption and repayment of notes payable
|
|
—
|
|
|
(1
|
)
|
|
(4
|
)
|
|
—
|
|
|
(5
|
)
|
|||||
Other
|
|
1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|||||
Net cash used for financing activities
|
|
9
|
|
|
(66
|
)
|
|
(344
|
)
|
|
—
|
|
|
(401
|
)
|
|||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
|
—
|
|
|
—
|
|
|
13
|
|
|
—
|
|
|
13
|
|
|||||
Net decrease in cash, cash equivalents and restricted cash
|
|
(100
|
)
|
|
(38
|
)
|
|
(80
|
)
|
|
—
|
|
|
(218
|
)
|
|||||
Cash, cash equivalents and restricted cash at beginning of period
|
|
147
|
|
|
78
|
|
|
421
|
|
|
—
|
|
|
646
|
|
|||||
Cash, cash equivalents and restricted cash at end of period
|
|
$
|
47
|
|
|
$
|
40
|
|
|
$
|
341
|
|
|
$
|
—
|
|
|
$
|
428
|
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
(dollars in millions, except per share data)
|
||||||||||||||
Net external sales
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
|
|
|
|
|
|
|
||||||||
Polyethylene
|
|
$
|
387
|
|
|
$
|
358
|
|
|
$
|
756
|
|
|
$
|
744
|
|
Styrene, feedstock and other
|
|
95
|
|
|
131
|
|
|
229
|
|
|
288
|
|
||||
Total Olefins
|
|
482
|
|
|
489
|
|
|
985
|
|
|
1,032
|
|
||||
Vinyls
|
|
|
|
|
|
|
|
|
||||||||
PVC, caustic soda and other
|
|
1,396
|
|
|
1,157
|
|
|
2,754
|
|
|
2,288
|
|
||||
Building products
|
|
357
|
|
|
333
|
|
|
646
|
|
|
602
|
|
||||
Total Vinyls
|
|
1,753
|
|
|
1,490
|
|
|
3,400
|
|
|
2,890
|
|
||||
Total
|
|
$
|
2,235
|
|
|
$
|
1,979
|
|
|
$
|
4,385
|
|
|
$
|
3,922
|
|
|
|
|
|
|
|
|
|
|
||||||||
Income (loss) from operations
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
$
|
158
|
|
|
$
|
143
|
|
|
$
|
321
|
|
|
$
|
323
|
|
Vinyls
|
|
271
|
|
|
141
|
|
|
537
|
|
|
211
|
|
||||
Corporate and other
|
|
(25
|
)
|
|
(20
|
)
|
|
(53
|
)
|
|
(36
|
)
|
||||
Total income from operations
|
|
404
|
|
|
264
|
|
|
805
|
|
|
498
|
|
||||
Interest expense
|
|
(31
|
)
|
|
(39
|
)
|
|
(68
|
)
|
|
(79
|
)
|
||||
Other income, net
|
|
8
|
|
|
2
|
|
|
30
|
|
|
9
|
|
||||
Provision for income taxes
|
|
93
|
|
|
68
|
|
|
182
|
|
|
124
|
|
||||
Net income
|
|
288
|
|
|
159
|
|
|
585
|
|
|
304
|
|
||||
Net income attributable to noncontrolling interests
|
|
10
|
|
|
6
|
|
|
20
|
|
|
13
|
|
||||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
278
|
|
|
$
|
153
|
|
|
$
|
565
|
|
|
$
|
291
|
|
Diluted earnings per share
|
|
$
|
2.12
|
|
|
$
|
1.17
|
|
|
$
|
4.31
|
|
|
$
|
2.23
|
|
EBITDA
(1)
|
|
$
|
568
|
|
|
$
|
411
|
|
|
$
|
1,147
|
|
|
$
|
802
|
|
(1)
|
See "Reconciliation of EBITDA to Net Income and to Net Cash Provided by Operating Activities" below.
|
|
|
Three Months Ended June 30, 2018
|
|
Six Months Ended June 30, 2018
|
||||||||
|
|
Average
Sales Price |
|
Volume
|
|
Average
Sales Price |
|
Volume
|
||||
Product sales price and volume percentage change from prior-year period
|
|
|
|
|
|
|
|
|
||||
Olefins
|
|
+3.0
|
%
|
|
-4.4
|
%
|
|
+2.6
|
%
|
|
-7.1
|
%
|
Vinyls
|
|
+8.5
|
%
|
|
+9.1
|
%
|
|
+10.4
|
%
|
|
+7.3
|
%
|
Company
|
|
+7.1
|
%
|
|
+5.8
|
%
|
|
+8.3
|
%
|
|
+3.5
|
%
|
|
|
|
|
|
|
|
|
|
||||
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||
Average industry prices
(1)
|
|
|
|
|
|
|
|
|
||||
Ethane (cents/lb)
|
|
9.7
|
|
|
8.3
|
|
|
9.1
|
|
|
8.1
|
|
Propane (cents/lb)
|
|
20.7
|
|
|
14.9
|
|
|
20.5
|
|
|
15.9
|
|
Ethylene (cents/lb)
(2)
|
|
14.8
|
|
|
27.6
|
|
|
19.2
|
|
|
29.4
|
|
Polyethylene (cents/lb)
(3)
|
|
73.7
|
|
|
69.0
|
|
|
73.7
|
|
|
68.2
|
|
Styrene (cents/lb)
(4)
|
|
93.0
|
|
|
84.4
|
|
|
95.6
|
|
|
85.0
|
|
Caustic soda ($/short ton)
(5)
|
|
795.0
|
|
|
623.3
|
|
|
771.7
|
|
|
595.8
|
|
Chlorine ($/short ton)
(6)
|
|
347.5
|
|
|
325.0
|
|
|
340.0
|
|
|
315.0
|
|
PVC (cents/lb)
(7)
|
|
67.5
|
|
|
62.5
|
|
|
67.3
|
|
|
61.3
|
|
(1)
|
Industry pricing data was obtained from IHS Markit ("IHS"). We have not independently verified the data.
|
(2)
|
Represents average North American spot prices of ethylene over the period as reported by IHS.
|
(3)
|
Represents average North American net transaction prices of polyethylene low density GP-Film grade over the period as reported by IHS.
|
(4)
|
Represents average North American contract prices of styrene over the period as reported by IHS.
|
(5)
|
Represents average North American United States Gulf Coast undiscounted contract prices of caustic soda over the period as reported by IHS. During the first quarter of 2018, IHS discontinued the previous caustic soda index that we used. For comparability, the average 2017 caustic soda is based on the current index.
|
(6)
|
Represents average North American contract prices of chlorine (into chemicals) over the period as reported by IHS.
|
(7)
|
Represents average North American contract prices of polyvinyl chloride (PVC) over the period as reported by IHS.
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
(dollars in millions)
|
||||||||||||||
Net cash provided by operating activities
|
|
$
|
324
|
|
|
$
|
323
|
|
|
$
|
549
|
|
|
$
|
480
|
|
Changes in operating assets and liabilities and other
|
|
(7
|
)
|
|
(143
|
)
|
|
81
|
|
|
(161
|
)
|
||||
Deferred income taxes
|
|
(29
|
)
|
|
(21
|
)
|
|
(45
|
)
|
|
(15
|
)
|
||||
Net income
|
|
288
|
|
|
159
|
|
|
585
|
|
|
304
|
|
||||
Add:
|
|
|
|
|
|
|
|
|
||||||||
Depreciation and amortization
|
|
156
|
|
|
145
|
|
|
312
|
|
|
295
|
|
||||
Interest expense
|
|
31
|
|
|
39
|
|
|
68
|
|
|
79
|
|
||||
Provision for income taxes
|
|
93
|
|
|
68
|
|
|
182
|
|
|
124
|
|
||||
EBITDA
|
|
$
|
568
|
|
|
$
|
411
|
|
|
$
|
1,147
|
|
|
$
|
802
|
|
•
|
future operating rates, margins, cash flows and demand for our products;
|
•
|
industry market outlook, including the price of crude oil;
|
•
|
production capacities;
|
•
|
currency devaluation;
|
•
|
our ability to borrow additional funds under the Credit Agreement;
|
•
|
our ability to meet our liquidity needs;
|
•
|
our ability to meet debt obligations under our debt instruments;
|
•
|
our intended quarterly dividends;
|
•
|
future capacity additions and expansions in the industry;
|
•
|
timing, funding and results of capital projects, such as the construction of the LACC plant and associated facilities;
|
•
|
pension plan obligations, funding requirements and investment policies;
|
•
|
compliance with present and future environmental regulations and costs associated with environmentally related penalties, capital expenditures, remedial actions and proceedings, including any new laws, regulations or treaties that may come into force to limit or control carbon dioxide and other greenhouse gases emissions or to address other issues of climate change;
|
•
|
effects of pending legal proceedings; and
|
•
|
timing of and amount of capital expenditures.
|
•
|
general economic and business conditions;
|
•
|
the cyclical nature of the chemical industry;
|
•
|
the availability, cost and volatility of raw materials and energy;
|
•
|
uncertainties associated with the United States, European and worldwide economies, including those due to political tensions and unrest in the Middle East, the Commonwealth of Independent States (including Ukraine) and elsewhere;
|
•
|
current and potential governmental regulatory actions in the United States and other countries and political unrest in other areas, including environmental regulations;
|
•
|
industry production capacity and operating rates;
|
•
|
the supply/demand balance for our products;
|
•
|
competitive products and pricing pressures;
|
•
|
instability in the credit and financial markets;
|
•
|
access to capital markets;
|
•
|
terrorist acts;
|
•
|
operating interruptions (including leaks, explosions, fires, weather-related incidents, mechanical failure, unscheduled downtime, labor difficulties, transportation interruptions, spills and releases and other environmental risks);
|
•
|
changes in laws or regulations, including trade policies;
|
•
|
technological developments;
|
•
|
foreign currency exchange risks;
|
•
|
our ability to implement our business strategies; and
|
•
|
creditworthiness of our customers.
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
Item 4.
|
Controls and Procedures
|
Item 1.
|
Legal Proceedings
|
•
|
In May 2013, an amendment to an existing consent order agreed to by the West Virginia Department of Environmental Protection and a predecessor of Axiall required that it, among other things, pay a penalty in the amount of $449,000 and continue certain corrective actions associated with discharges of hexachlorocyclohexane (commonly referred to as BHC) from the Natrium, West Virginia facility's effluent discharge outfalls. The penalty was paid and corrective actions required are on-going per a December 2016 agreement to extend the compliance date under the amended consent order. The amended consent order also imposes stipulated penalties for exceedances of the facility's interim effluent discharge limits, which penalties we believe may, in the aggregate, reach or exceed $100,000 by year end 2018.
|
•
|
During September 2010, our vinyls facilities in Lake Charles and Plaquemine each received a Consolidated Compliance Order and Notice of Potential Penalty, alleging violations of various requirements of those facilities' air permits, based largely on self-reported permit deviations related to record-keeping violations. We have been negotiating a possible global settlement of these and several other matters with the Louisiana Department of Environmental Quality ("LDEQ"). In May 2018 we reached an agreement in principal with the LDEQ to resolve these consolidated enforcement matters for a penalty of $162,500. The settlement agreement is being prepared and when finalized will be subject to public comment and approval by the Louisiana Attorney General.
|
•
|
For several years, the Environmental Protection Agency (the "EPA") has been conducting an enforcement initiative against petroleum refineries and petrochemical plants with respect to emissions from flares. On April 21, 2014, we received a Clean Air Act Section 114 Information Request from the EPA which sought information regarding flares at the Calvert City, Kentucky facility and certain Lake Charles facilities. The EPA has informed us that the information provided leads the EPA to believe that some of the flares are out of compliance with applicable standards. The EPA has indicated that it is seeking a consent decree that would obligate us to take corrective actions relating to the alleged noncompliance. We believe the resolution of these matters may require the payment of a monetary sanction in excess of
$100,000
.
|
•
|
Regional offices of the EPA have investigated, and in some cases inspected, our compliance with Risk Management Program requirements under the Clean Air Act at our Calvert City, Kentucky; Natrium, West Virginia and Geismar, Louisiana facilities. We believe the resolution of these matters may require the payment of a monetary sanction in excess of
$100,000
.
|
•
|
On November 24, 2014, we entered into an Agreed Order with the Kentucky Energy and Environmental Cabinet ("KEEC") regarding our Kentucky Pollutant Discharge Elimination System ("KPDES") permit limits for hexachlorobenzene and mercury at our Calvert City, Kentucky facility. We and the KEEC recently negotiated a new Agreed Order under which we will be subject to new interim discharge limits for hexachlorobenzene in addition to accompanying stipulated penalties for exceedances of those interim discharge limits. The new Agreed Order further requires us to seek a formal variance from the Tier 3 limit for hexachlorobenzene during the interim period. A formal variance requires public comment and approval by both the KEEC and the EPA.
|
•
|
The KEEC has indicated that it intends to proceed with enforcement on two Notices of Violation ("NOVs") received by our Calvert City, Kentucky facility in December 2016 and May 2017. The NOVs allege violations of state and federal air requirements in connection with the operation of the olefins unit at the facility. We are engaged in negotiations with the KEEC to resolve these alleged violations. We believe the resolution of these matters may require the payment of a monetary sanction in excess of
$100,000
.
|
Item 1A.
|
Risk Factors
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
Period
|
|
Total Number
of Shares
Purchased
(1)
|
|
Average Price
Paid Per
Share
|
|
Total Number
of Shares
Purchased as Part
of Publicly
Announced Plans
or Programs
(2)
|
|
Maximum Number
(or Approximate
Dollar Value) of
Shares that
May Yet Be
Purchased Under the
Plans or Programs
(2)
|
||||||
April 2018
|
|
165
|
|
|
$
|
111.25
|
|
|
—
|
|
|
$
|
171,285,000
|
|
May 2018
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
171,285,000
|
|
June 2018
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
171,285,000
|
|
|
|
165
|
|
|
$
|
111.25
|
|
|
—
|
|
|
|
(1)
|
Represents shares withheld in satisfaction of withholding taxes due upon the vesting of restricted stock units granted to our employees under the 2013 Plan.
|
(2)
|
In November 2014, our Board of Directors authorized a $250 million share repurchase program (the "2014 Program"). In November 2015, our Board of Directors approved the expansion of the 2014 Program by an additional $150 million. As of
June 30, 2018
,
4,193,598
shares of common stock had been acquired at an aggregate purchase price of approximately
$229 million
under the 2014 Program. Transaction fees and commissions are not reported in the average price paid per share in the table above. Decisions regarding the amount and the timing of purchases under the 2014 Program will be influenced by our cash on hand, our cash flow from operations, general market conditions and other factors. The 2014 Program may be discontinued by our Board of Directors at any time.
|
Item 6.
|
Exhibits
|
Exhibit No.
|
|
EXHIBIT INDEX
|
4.1
|
|
|
|
|
|
31.1†
|
|
|
|
|
|
31.2†
|
|
|
|
|
|
32.1#
|
|
|
|
|
|
101.INS†
|
|
XBRL Instance Document
|
|
|
|
101.SCH†
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
101.CAL†
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
101.DEF†
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
101.LAB†
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
101.PRE†
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
†
|
Filed herewith.
|
#
|
Furnished herewith.
|
|
|
|
|
WESTLAKE CHEMICAL CORPORATION
|
||
|
|
|
|
|||
Date:
|
August 2, 2018
|
|
|
By:
|
|
/
S
/ A
LBERT
C
HAO
|
|
|
|
|
|
|
Albert Chao
|
|
|
|
|
|
|
President and Chief Executive Officer
(Principal Executive Officer)
|
|
|
|
|
|||
Date:
|
August 2, 2018
|
|
|
By:
|
|
/
S
/ M. S
TEVEN
B
ENDER
|
|
|
|
|
|
|
M. Steven Bender
|
|
|
|
|
|
|
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|